Accuray Incorporated Announces Amendment to Consulting Agreement with Dedication Capital, LLC

April 7, 2026 — Madison, WI: Accuray Incorporated (NASDAQ: ARAY), a leading provider in the surgical and medical instruments sector, has filed a Form 8-K disclosing a significant amendment to its Consulting Agreement with Dedication Capital, LLC, an affiliate of board director Steven F. Mayer. This amendment brings material changes to both compensation and equity vesting terms, and is anticipated to deliver substantial cost savings to the company.

Key Points of the Report

• Material Amendment to Consulting Agreement: On April 1, 2026, Accuray entered into a letter agreement amending its prior Consulting Agreement with Dedication Capital, originally dated October 18, 2025. The amendment affects both cash compensation and equity vesting terms for the consulting relationship.
• Reduction in Compensation:
  • The amendment reduces the Base Consulting Fee by 50% for the period after March 31, 2026, through October 31, 2026.
  • The minimum amount payable for the cash incentive award for fiscal year ended June 30, 2026, is reduced from \$265,625 to \$132,812.50.
  • The mid-year cash incentive award for the fiscal quarter ended September 30, 2026, is reduced from \$109,375 to \$54,688.
• Changes to Equity Vesting:
  • The time-based vesting requirement is deemed satisfied as of April 1, 2026 for 916,336 shares of Initial Restricted Shares and 100% of the Performance Stock Awards (PSAs).
  • The remaining 333,004 Initial Restricted Shares will vest on October 31, 2026, in accordance with the original equity plan documents.
• Extension of Consulting Relationship:
  • The consulting agreement’s End Date is now extended to October 31, 2026.
• Cost Savings:
  • The amendment is expected to result in at least \$362,500 in cash savings for Accuray Incorporated.
• Exhibit Filed:
  • The full Letter Agreement Amendment is filed as Exhibit 10.1 to the Form 8-K.

Shareholder-Relevant and Price-Sensitive Information

• Cost Management and Profitability: The reduction in both base fees and incentive awards directly contributes to improved cost control and could positively impact Accuray’s bottom line for the remainder of FY2026 and into FY2027.
• Governance and Related Party Transactions: Because Dedication Capital is affiliated with a board member (Steven F. Mayer), the amendment and its transparent disclosure signal continued attention to governance and related-party dealings, which can be critical for investor confidence.
• Equity Vesting Adjustments: The immediate vesting of a significant portion of restricted shares and PSAs, plus the scheduled vesting of remaining shares, may affect the timing of share-based compensation expenses and could influence share float, depending on how these shares are handled post-vesting.
• Potential Share Price Impact: Investors may view the cost savings and tightened compensation structure as positive for earnings. However, the accelerated vesting of equity may introduce new shares into the market, which could put pressure on share price if sold.

Additional Details

• Company Profile: Accuray Incorporated is headquartered at 1240 Deming Way, Madison, WI 53717, and is listed under the trading symbol ARAY on the Nasdaq Stock Market.
• Certifying Officers: The 8-K filing is signed by Ali Pervaiz, Senior Vice President & Chief Financial Officer. The amendment itself is executed by Stephen R. La Neve (Accuray CEO) and Steven F. Mayer (CEO of Dedication Capital, LLC).
• No Emerging Growth Company Status: Accuray is not classified as an Emerging Growth Company under SEC rules.

Conclusion

The announced amendment is material for investors as it demonstrates Accuray’s commitment to cost management and transparent governance, especially in related-party transactions. The anticipated cash savings may have a positive impact on profitability, while the changes in equity vesting could affect share supply dynamics. Investors should review the full text of the amendment (Exhibit 10.1) for further details and monitor subsequent filings for any changes in share ownership or board relationships.

Disclaimer: This article is based on Accuray Incorporated’s SEC filings as of April 7, 2026, and is intended for informational purposes only. It does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making investment decisions. The author and publisher are not responsible for any actions taken based on the information provided herein.

View ACCURAY INC Historical chart here